Heart failure with preserved ejection fractiona growing epidemic or 'The Emperors New Clothes?'

European Journal of Heart Failure

Volumn 13, Issue 1, 2011, Pages 11-13

  Pieske, Burkert ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CLINICAL FEATURE; CLINICAL TRIAL; DIASTOLIC HEART FAILURE; HEART EJECTION FRACTION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; LUNG CONGESTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYMPTOM;

EUROPE; HEART FAILURE; HUMANS; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 78650360633     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq215     Document Type: Review

References (23)

1. Topol EJ Traill TA Fortuin NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. New Engl J Med 1985;321:277-283.
2. Bench T Burkhoff D O'Connell JB Costanzo MR Abraham WT St John Sutton M Maurer MS. Heart failure with normal ejection fraction: consideration of mechanisms other than diastolic dysfunction. Curr Heart Fail Rep 2009;6:57-61.
3. Vinereanu D Nicolaides E Tweddel AC Fraser AG. 'Pure' diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur J Heart Fail 2005;7:820-828.
4. He KL Burkhoff D Leng WX Fan L Wang J Maurer MS. Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions .55% versus 40% to 55% versus40%40%. Am J Cardiol 2009;103:845-853.
5. De Keulenaer GW Brutsaert D. Systolic and diastolic heart failure: different phe-notypes of the same disease? Eur J Heart Fail 2007;9:136-143. (Pubitemid 46394077)
6. Maurer MS Burkhoff D Fried LP Gottdiener J King DL Kitzman DW. Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol 2007;49: 972-981.
7. Lam CS Roger VL Rodeheffer RJ Bursi F Borlaug BA Ommen SR Kass DA Redfield MM. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County Minnesota. Circulation 2007;115:1982-1990.
8. Borbély A van Heerebeek L Paulus WJ. Transcriptional and posttranslational modifications of titin: implications for diastole. Circ Res 2009;104:12-14.
9. López B González A D́?ez J. Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation 2010;121:1645-1654.
10. Paulus WJ Tschöpe C Sanderson JE Rusconi C Flachskampf FA Rademakers FE Marino P Smiseth OA De Keulenaer G Leite-Moreira AF Borbély A Edes I Handoko ML Heymans S Pezzali N Pieske B Dickstein K Fraser AG Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-2550.
11. Kuznetsova T Herbots L López B Jin Y Richart T Thijs L González A Herregods MC Fagard RH D́?ez J Staessen JA. Prevalence of left ventricular dias-tolic dysfunction in a general population. Circ Heart Fail 2009;2:105-115.
12. Redfield MM Jacobsen SJ Burnett JC Jr Mahoney DW Bailey KR Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202.
13. Owan TE Hodge DO Herges RM Jacobsen SJ Roger VL Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-259.
14. Edelmann F Schmidt AG Gelbrich G Binder L Herrmann-Lingen C Halle M Hasenfuss G Wachter R Pieske B. Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind randomized placebo-controlled parallel group study to determine the effects of spironolac-tone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF). Eur J Heart Fail 2010;12:874-882.
15. Lam CS Roger VL Rodeheffer RJ Borlaug BA Enders FT Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol 2009;53:1119-1126.
16. Borlaug BA Olson TP Lam CS Flood KS Lerman A Johnson BD Redfield MM. Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010;56:845-854.
17. Sanderson JE. Exercise echocardiography and the diagnosis of heart failure with a normal ejection fraction. Heart 2010;96:997-998.
18. Borlaug BA Nishimura RA Sorajja P Lam CS Redfield MM. Exercise hemody-namics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010;3:588-595.
19. Iwanaga Y Nishi I Furuichi S Noguchi T Sase K Kihara Y Goto Y Nonogi H. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006;21:742-748.
20. Paulus WJ van Ballegoij JJ. Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol 2010;55:526-537.
21. Lieb W Xanthakis V Sullivan LM Aragam J Pencina MJ Larson MG Benjamin EJ Vasan RS. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation 2009;119:3085-3092.
22. Arbab-Zadeh A Dijk E Prasad A Fu Q Torres P Zhang R Thomas JD Palmer D Levine BD. Effect of aging and physical activity on left ventricular compliance. Circulation 2004;110:1799-1805.
23. Lam CS Donal E Kraigher-Krainer E Vasan RS. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail 2011;13:18-28.